BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2010
View Archived Issues
New antibiotics for multidrug-resistant pathogens in preclinical/clinical evaluation
Read More
Zealand Pharma's ZP-2307 shows bone anabolic activity in vivo
Read More
Subanalyses of CLARITY data support benefits of cladribine tablets
Read More
EC grants orphan drug status for eflornithine in familial adenomatous polyposis
Read More
Sequella and LMU to collaborate on phase II SQ-109 trials
Read More
Treatment begins in phase I/II alpha-1-antitrypsin trial in type 1 diabetes
Read More
ONO-4641 shows safety and tolerability in phase I trial in MS
Read More
Phase I trial evaluates MVA-BN PRO in castration-resistant prostate cancer
Read More
New nicotinic acetylcholine alpha4beta2 receptor modulators claimed by NeuroSearch
Read More
New diacylglycerol O-acyltransferase 1 inhibitors disclosed
Read More
Plexxikon presents new inhibitors of protein kinases
Read More
Merck & Co. describes novel P2X3 receptor antagonists
Read More
Phase II trial begins of CAL-101/rituximab combination in CLL
Read More
ADL-5945 enters proof-of-concept phase II trial in opioid-induced constipation
Read More
Karmanos Institute receives grant to fund testing of HER2Bi-armed activated T cells
Read More
BEMA Fentanyl citrate approved in Europe for breakthrough cancer pain
Read More
FDA approves Pradaxa for reducing risk of stroke in patients with nonvalvular AF
Read More
Roche files to extend indication of tocilizumab for systemic juvenile idiopathic arthritis
Read More
ImmuneWorks begins phase I trial of its lead compound for IPF
Read More
Alexza Pharma reacquires U.S. and Canadian rights for AZ-004
Read More
Daiichi Sankyo launches Inavir in Japan
Read More
FDA issues complete response letter regarding Byuderon NDA
Read More
MKC-1106-MT enters phase II trial in advanced melanoma
Read More
EC grants orphan drug status for nafamostat mesilate in cystic fibrosis
Read More
